CVSS 3.1
9.8 criticalCVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:HCritical (9.8) in typelevel fs2. EPSS 0.8% estimated probability of exploitation activity in the next 30 days. Fixed in co.fs2:fs2-io 3.2.11.
CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:H/I:H/A:Hco.fs2:fs2-io (Maven): fixed in 3.2.11co.fs2:fs2-io_2.12 (Maven): fixed in 3.2.11co.fs2:fs2-io_3 (Maven): fixed in 3.2.11co.fs2:fs2-io_2.13 (Maven): fixed in 3.2.11co.fs2:fs2-io_sjs1_2.13 (Maven): fixed in 3.2.11co.fs2:fs2-io_sjs1_3 (Maven): fixed in 3.2.11Explain CVE-2022-31183 for an engineer deciding whether to act. Use https://cve.bz/api/public/cves/CVE-2022-31183?via=ask-ai-copy and https://cve.bz/cve/CVE-2022-31183?via=ask-ai-copy as the source of truth: what is affected and which versions fix it, whether it is in CISA KEV, public exploits, and its EPSS (an internet-wide 30-day estimate of exploitation activity, not a forecast for my systems). If they give no fixed versions, use the CVE record https://cveawg.mitre.org/api/cve/CVE-2022-31183 or the vendor advisory, not third-party mirrors. Tell me how to check whether I am affected and how to verify a fix. Cite the sources and say where they are uncertain.Opens a third-party assistant; its answer is its own, not cve.bz's. The prompt holds only this CVE's id and public links.
From the NVD's CPE matches.
| Product | Affected |
|---|---|
| typelevel:fs2 | from 3.1.0 before 3.2.11 |
| Advisory | Ecosystem | Package | Affected | Fixed in |
|---|---|---|---|---|
| GHSA-2cpx-6pqp-wf35 | Maven | co.fs2:fs2-io | >=3.1.0 <3.2.11 | 3.2.11 |
| GHSA-2cpx-6pqp-wf35 | Maven | co.fs2:fs2-io_2.12 | >=3.1.0 <3.2.11 | 3.2.11 |
| GHSA-2cpx-6pqp-wf35 | Maven | co.fs2:fs2-io_3 | >=3.1.0 <3.2.11 | 3.2.11 |
| GHSA-2cpx-6pqp-wf35 | Maven | co.fs2:fs2-io_2.13 | >=3.1.0 <3.2.11 | 3.2.11 |
| GHSA-2cpx-6pqp-wf35 | Maven | co.fs2:fs2-io_sjs1_2.13 | >=3.1.0 <3.2.11 | 3.2.11 |
| GHSA-2cpx-6pqp-wf35 | Maven | co.fs2:fs2-io_sjs1_3 | >=3.1.0 <3.2.11 | 3.2.11 |
The attack patterns MITRE's CAPEC relates to this record's weaknesses, as MITRE names them. Credits.